Skip to content


Zinplava (bezlotoxumab) is an antibody pharmaceutical. Bezlotoxumab was first approved as Zinplava on 2016-10-21. It is used to treat clostridium infections in the USA. It has been approved in Europe to treat pseudomembranous enterocolitis.
Trade Name Zinplava
Common Name Bezlotoxumab
Indication clostridium infections, pseudomembranous enterocolitis
Drug Class Monoclonal antibodies
Get full access now